This Month's Tiny Gems - May 2013

FluoroPharma Medical, Inc. (FPMI)

FluoroPharma Medical, Inc. is focused on the $1.7 billion market for molecular imaging agents. The company is discovering and developing patented Positron Emission Tomography (PET) imaging products to improve patient management by evaluating cardiac disease at the cellular and molecular levels. The market growth for this imaging technology presents tremendous opportunity for innovative developments that address leading unmet medical needs.

Local Corp. (LOCM)

Local Corp. has demonstrated consistent progression since its inception in 1999, becoming one of the fastest growing online media companies in the nation. When Local Corp. completed its IPO in October 2004, its offering was ranked as one of the most successful in North America. Local Corp. was awarded its first patent in 2007, and now has eight patents and 11 more patents pending, including inbound marketing platform, Octane 360.

MELA Sciences, Inc. (MELA)

MELA Sciences, Inc. is focused on innovative medical technologies for the detection of melanoma, the deadliest form of skin cancer. Approximately 130,000 people are diagnosed with melanoma each year, and one person in the U.S. dies of melanoma every hour. With no cure for the disease in late stage, early detection is vital to survival, and MELA is developing its technologies to address this significant unmet medical need.